Authors




Richard Durham

Latest:

Identifying the Structure of an Unknown Impurity in a Topical Gel

This case study highlights analytical instrumentation and techniques that were used to identify an unknown impurity detected during routine release testing of a topical gel drug product.


Jerry Neal

Latest:

Identifying the Structure of an Unknown Impurity in a Topical Gel

This case study highlights analytical instrumentation and techniques that were used to identify an unknown impurity detected during routine release testing of a topical gel drug product.


Jerry Mizell

Latest:

Identifying the Structure of an Unknown Impurity in a Topical Gel

This case study highlights analytical instrumentation and techniques that were used to identify an unknown impurity detected during routine release testing of a topical gel drug product.


Matt Casteen

Latest:

Identifying the Structure of an Unknown Impurity in a Topical Gel

This case study highlights analytical instrumentation and techniques that were used to identify an unknown impurity detected during routine release testing of a topical gel drug product.


Gerry McNally

Latest:

Oral Dosage Form Innovation in OTC Pharmaceuticals

A quick look at the history of OTC dosage form development shows the importance of patient-centered innovation.









George I’ons

Latest:

The Design Driver for Biosimilar Adoption

Industry opportunities are increasing for biosimilars, but companies should pay close attention to delivery device design to facilitate success.






Nelson Labs

Latest:

E&L Testing to Ensure Compliance & Patient Safety

Extractables and leachables (E&L) testing for packaging-related impurities is essential to ensure cGMP compliance and, most importantly, patient safety.